Seizert Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,165	Closed	-$1.68M	–	177
2024 Q4	$1.68M	Sell	4,165 -6,546	-61%	-$3.03M	0.08%	111
2024 Q3	$4.98M	Buy	10,711 +20	+0.2%	+$9.61K	0.22%	81
2024 Q2	$5.01M	Sell	10,691 -1,466	-12%	-$636K	0.25%	71
2024 Q1	$5.08M	Sell	12,157 -415	-3%	-$175K	0.23%	72
2023 Q4	$5.12M	Sell	12,572 -4,823	-28%	-$1.78M	0.26%	71
2023 Q3	$6.05M	Sell	17,395 -335	-2%	-$117K	0.32%	59
2023 Q2	$6.24M	Sell	17,730 -11,069	-38%	-$3.73M	0.33%	60
2023 Q1	$9.07M	Sell	28,799 -7,582	-21%	-$2.27M	0.5%	52
2022 Q4	$10.5M	Sell	36,381 -3,438	-9%	-$1.05M	0.56%	48
2022 Q3	$11.5M	Sell	39,819 -165	-0.4%	-$47.5K	0.65%	46
2022 Q2	$11.3M	Sell	39,984 -94	-0.2%	-$25.2K	0.6%	46
2022 Q1	$10.5M	Buy	40,078 +1,480	+4%	+$351K	0.48%	53
2021 Q4	$8.48M	Buy	38,598 +3,640	+10%	+$708K	0.38%	62
2021 Q3	$6.34M	Buy	34,958 +1	+0%	+$195	0.29%	64
2021 Q2	$7.05M	Buy	34,957 +1,098	+3%	+$230K	0.34%	64
2021 Q1	$7.28M	Buy	+33,859	New	+$7.44M	0.38%	65